Dr. Brill & Partner’s Middle East Expansion to DuBiotech

Dubai, United Arab Emirates - Thursday, January 30th 2014 [ME NewsWire]
DuBiotech, Dubai’s dedicated biotechnology and research park announced that Dr Brill & Partner GmbH, a German based Institute for hygiene and microbology has established its first Middle East operating subsidiary at the freezone. The Dr Brill & Partner Group will provide the region with high quality hygiene and microbiology consulting, training and laboratory services to assist the Government’s drive to place public health and safety at the top of its priorities.

The announcement was made at a reception hosted on the side-lines of Arab Health 2014, and was attended by   Marwan Abdulaziz, Executive Director, Dubiotech, Elke Badde, State Counsellor, Hamburg Ministry of Health and Consumer Protection, Dr Bassem El-Sayed Zayed from Ministry of Health Oman,  Prof.  Dr. Hans-Jörg    Schmidt-Trenz   , CEO of Hamburg Chamber of Commerce and Industry, including senior officials from Germany, the UAE and the region.

Commenting on the occasion, Dr Florian H.H. Brill, Owner and Managing Director of Dr Brill & Partner said: “The Middle Eastern region has significant potential for developing a thriving health and life science sector. There is high demand for quality healthcare due to the prevalence of diseases specific to the region such as diabetes and cardiovascular diseases. At Dr. Brill & Partners, we focus on delivering qualitative consulting and training services with the aim of establishing the necessary healthcare standards specialized in infection prevention and control. This is of upmost importance in order to provide the rising population with a world class healthcare system. Therefore, we established an Infection Control Accreditation Program, which is designed for the Middle East Region’s healthcare facilities such as hospitals, dental and veterinary clinics.

“TECOM Investment’s DuBiotech was our first choice when searching for a regional destination in line with our expansion plans. This was due to the essential infrastructure, research facilities and various business setup services they provide to the life sciences community. The freezone has established a community of like-minded life science professionals, which aids in the success of our objectives by providing health solutions,” Dr.  Brill added.

Marwan Abdulaziz, Executive Director, TECOM Investment’s DuBiotech said: “It is very important to have well-established health and safety programmes and certification in place for patient’s safety. This is particularly important if we are to truly develop the UAE as a medical tourism hub in the region and to provide our residents with the best possible care.

“DuBiotech is dedicated to fostering and facilitating innovation, growth and collaboration within the life sciences industry. As part of this, we strive to ensure our business partners receive full support and assistance required to achieve their objectives and commercial goals to enable their success, but ultimately to ensure that this success translates to better healthcare for our nation.”

ENDS

NOTES TO EDITORS

About DuBiotech

Dubai Biotechnology and Research Park (DuBiotech), a member of TECOM Investments, is a freezone business park dedicated to fostering the growth of the life sciences industry in the region. DuBiotech was established to support the Government of Dubai’s vision to transform the UAE into a knowledge-based economy and develop the region’s talent pool.

DuBiotech offers world-class infrastructure and cutting edge research and development facilities, specifically designed and built for the field of biotechnology, pharmaceutical, medical and scientific device, food and agricultural industries. The freezone can support both start-ups and international firms looking for a regional base for their Middle East or global operations. The park is central to a community that is committed to the industry’s success by bringing together business, regulators and Government in partnership.

Since its launch in 2005, DuBiotech has rapidly grown into a community of 146 life sciences companies such as Pfizer, Genzyme, Merck-Serono, Amgen, Bristol-Myers Squibb, Maquet, National Reference Lab, Firmenich and IFF.

For further information on DuBiotech, please visit our website: www.dubiotech.ae.

About Dr. Brill Group

Dr. Brill Group provides consulting, training and laboratory services in the area of hygiene and microbiology: consulting and training services consisting of e.g. hospital and industrial hygiene consulting, scientific services with regard to product development and registration. Laboratory services include efficacy testing of disinfectants, antimicrobial wound care products and antiseptics, preservation testing, microbiological quality control, development and validation of microbiological test methods, bioburden and sterility testing. The test lab is accredited according to DIN EN ISO/IEC 17025 and recognized by the ZLG (German national state agency).

Contacts

Media Enquiries

Nicola Hooper, Bell Pottinger:+971 55 886 2254

Layla Haroon, Bell Pottinger: +971 55 636 0425



DuBiotech Enquiries

Hamad Al Zarooni, Sales Manager, TECOM investments Sciences Cluster: +971 55 7254444